187 related articles for article (PubMed ID: 20724469)
1. Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.
Tiberti N; Hainard A; Lejon V; Robin X; Ngoyi DM; Turck N; Matovu E; Enyaru J; Ndung'u JM; Scherl A; Dayon L; Sanchez JC
Mol Cell Proteomics; 2010 Dec; 9(12):2783-95. PubMed ID: 20724469
[TBL] [Abstract][Full Text] [Related]
2. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid-Derived Microvesicles From Sleeping Sickness Patients Alter Protein Expression in Human Astrocytes.
Dozio V; Lejon V; Mumba Ngoyi D; Büscher P; Sanchez JC; Tiberti N
Front Cell Infect Microbiol; 2019; 9():391. PubMed ID: 31824868
[TBL] [Abstract][Full Text] [Related]
4. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
Hainard A; Tiberti N; Robin X; Lejon V; Ngoyi DM; Matovu E; Enyaru JC; Fouda C; Ndung'u JM; Lisacek F; Müller M; Turck N; Sanchez JC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e459. PubMed ID: 19554086
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.
Tiberti N; Hainard A; Lejon V; Courtioux B; Matovu E; Enyaru JC; Robin X; Turck N; Kristensson K; Ngoyi DM; Vatunga GM; Krishna S; Büscher P; Bisser S; Ndung'u JM; Sanchez JC
PLoS One; 2012; 7(7):e40909. PubMed ID: 22815865
[TBL] [Abstract][Full Text] [Related]
6. Human African trypanosomiasis.
Lejon V; Bentivoglio M; Franco JR
Handb Clin Neurol; 2013; 114():169-81. PubMed ID: 23829907
[TBL] [Abstract][Full Text] [Related]
7. Dot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African trypanosomiasis.
Courtioux B; Bisser S; M'belesso P; Ngoungou E; Girard M; Nangouma A; Josenando T; Jauberteau-Marchan MO; Bouteille B
J Clin Microbiol; 2005 Sep; 43(9):4789-95. PubMed ID: 16145142
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics.
Tiberti N; Sanchez JC
Data Brief; 2015 Sep; 4():400-5. PubMed ID: 26306311
[TBL] [Abstract][Full Text] [Related]
9. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
[TBL] [Abstract][Full Text] [Related]
10. Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness.
Lejon V; Robays J; N'Siesi FX; Mumba D; Hoogstoel A; Bisser S; Reiber H; Boelaert M; Büscher P
Clin Vaccine Immunol; 2007 Jun; 14(6):732-7. PubMed ID: 17428948
[TBL] [Abstract][Full Text] [Related]
11. Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.
Gineau L; Courtin D; Camara M; Ilboudo H; Jamonneau V; Dias FC; Tokplonou L; Milet J; Mendonça PB; Castelli EC; Camara O; Camara M; Favier B; Rouas-Freiss N; Moreau P; Donadi EA; Bucheton B; Sabbagh A; Garcia A
Clin Infect Dis; 2016 Nov; 63(9):1189-1197. PubMed ID: 27470243
[TBL] [Abstract][Full Text] [Related]
12. Using detergent-enhanced LAMP for African trypanosome detection in human cerebrospinal fluid and implications for disease staging.
Grab DJ; Nikolskaia OV; Courtioux B; Thekisoe OMM; Magez S; Bogorad M; Dumler JS; Bisser S
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007631. PubMed ID: 31425540
[TBL] [Abstract][Full Text] [Related]
13. The challenging problem of disease staging in human African trypanosomiasis (sleeping sickness): a new approach to a circular question.
Njamnshi AK; Gettinby G; Kennedy PGE
Trans R Soc Trop Med Hyg; 2017 May; 111(5):199-203. PubMed ID: 28957467
[TBL] [Abstract][Full Text] [Related]
14. Parasites in the brain? The search for sleeping sickness biomarkers.
Burchmore R
Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1283-6. PubMed ID: 23241185
[TBL] [Abstract][Full Text] [Related]
15. [Human African trypanosomiasis].
Dumas M; Bouteille B
C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
[TBL] [Abstract][Full Text] [Related]
16. Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.
Tiberti N; Lejon V; Hainard A; Courtioux B; Robin X; Turck N; Kristensson K; Matovu E; Enyaru JC; Mumba Ngoyi D; Krishna S; Bisser S; Ndung'u JM; Büscher P; Sanchez JC
PLoS Negl Trop Dis; 2013; 7(2):e2088. PubMed ID: 23469311
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
Kennedy PGE; Rodgers J
Front Immunol; 2019; 10():39. PubMed ID: 30740102
[TBL] [Abstract][Full Text] [Related]
18. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis.
Amin DN; Rottenberg ME; Thomsen AR; Mumba D; Fenger C; Kristensson K; Büscher P; Finsen B; Masocha W
J Infect Dis; 2009 Nov; 200(10):1556-65. PubMed ID: 19827943
[TBL] [Abstract][Full Text] [Related]
19. Priorities for the elimination of sleeping sickness.
Welburn SC; Maudlin I
Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
